These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 17413128)

  • 21. Fiber atrophy, oxidative stress, and oxidative fiber reduction are the attributes of different phenotypes in chronic obstructive pulmonary disease patients.
    Gouzi F; Abdellaoui A; Molinari N; Pinot E; Ayoub B; Laoudj-Chenivesse D; Cristol JP; Mercier J; Hayot M; Préfaut C
    J Appl Physiol (1985); 2013 Dec; 115(12):1796-805. PubMed ID: 24136107
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oxidised proteins and superoxide anion production in the diaphragm of severe COPD patients.
    Marin-Corral J; Minguella J; Ramírez-Sarmiento AL; Hussain SN; Gea J; Barreiro E
    Eur Respir J; 2009 Jun; 33(6):1309-19. PubMed ID: 19196822
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diaphragm muscle fiber weakness in pulmonary hypertension.
    de Man FS; van Hees HW; Handoko ML; Niessen HW; Schalij I; Humbert M; Dorfmüller P; Mercier O; Bogaard HJ; Postmus PE; Westerhof N; Stienen GJ; van der Laarse WJ; Vonk-Noordegraaf A; Ottenheijm CA
    Am J Respir Crit Care Med; 2011 May; 183(10):1411-8. PubMed ID: 21131469
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cigarette smoke-induced oxidative stress: A role in chronic obstructive pulmonary disease skeletal muscle dysfunction.
    Barreiro E; Peinado VI; Galdiz JB; Ferrer E; Marin-Corral J; Sánchez F; Gea J; Barberà JA;
    Am J Respir Crit Care Med; 2010 Aug; 182(4):477-88. PubMed ID: 20413628
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Role of expiratory muscles in COPD patients].
    Bieleń P; Sliwiński P
    Pneumonol Alergol Pol; 2002; 70(7-8):387-97. PubMed ID: 12708080
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Respiratory muscle function and activation in chronic obstructive pulmonary disease.
    McKenzie DK; Butler JE; Gandevia SC
    J Appl Physiol (1985); 2009 Aug; 107(2):621-9. PubMed ID: 19390004
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adaptation of the diaphragm and the vastus lateralis in mild-to-moderate COPD.
    Doucet M; Debigaré R; Joanisse DR; Côté C; Leblanc P; Grégoire J; Deslauriers J; Vaillancourt R; Maltais F
    Eur Respir J; 2004 Dec; 24(6):971-9. PubMed ID: 15572541
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Atrophy and hypertrophy signalling in the diaphragm of patients with COPD.
    Testelmans D; Crul T; Maes K; Agten A; Crombach M; Decramer M; Gayan-Ramirez G
    Eur Respir J; 2010 Mar; 35(3):549-56. PubMed ID: 19717478
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Exercise-induced systemic effects in muscle-wasted patients with COPD.
    Van Helvoort HA; Heijdra YF; Thijs HM; Viña J; Wanten GJ; Dekhuijzen PN
    Med Sci Sports Exerc; 2006 Sep; 38(9):1543-52. PubMed ID: 16960513
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Levosimendan enhances force generation of diaphragm muscle from patients with chronic obstructive pulmonary disease.
    van Hees HW; Dekhuijzen PN; Heunks LM
    Am J Respir Crit Care Med; 2009 Jan; 179(1):41-7. PubMed ID: 18990676
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pathophysiology of muscle dysfunction in COPD.
    Gea J; Agustí A; Roca J
    J Appl Physiol (1985); 2013 May; 114(9):1222-34. PubMed ID: 23519228
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Clinical investigation of diaphragmatic function. Relationships with the biology of muscle].
    Perez T
    Rev Mal Respir; 2000 Jun; 17(2 Pt 2):591-6. PubMed ID: 10939120
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reduced force of diaphragm muscle fibers in patients with chronic thromboembolic pulmonary hypertension.
    Manders E; Bonta PI; Kloek JJ; Symersky P; Bogaard HJ; Hooijman PE; Jasper JR; Malik FI; Stienen GJ; Vonk-Noordegraaf A; de Man FS; Ottenheijm CA
    Am J Physiol Lung Cell Mol Physiol; 2016 Jul; 311(1):L20-8. PubMed ID: 27190061
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metabolic capacity of the diaphragm in patients with COPD.
    Wijnhoven JH; Janssen AJ; van Kuppevelt TH; Rodenburg RJ; Dekhuijzen PN
    Respir Med; 2006 Jun; 100(6):1064-71. PubMed ID: 16257195
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Proteasome inhibition improves diaphragm function in an animal model for COPD.
    van Hees H; Ottenheijm C; Ennen L; Linkels M; Dekhuijzen R; Heunks L
    Am J Physiol Lung Cell Mol Physiol; 2011 Jul; 301(1):L110-6. PubMed ID: 21460121
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Passive properties of the diaphragm in COPD.
    Moore AJ; Stubbings A; Swallow EB; Dusmet M; Goldstraw P; Porcher R; Moxham J; Polkey MI; Ferenczi MA
    J Appl Physiol (1985); 2006 Nov; 101(5):1400-5. PubMed ID: 16840573
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cellular markers of muscle atrophy in chronic obstructive pulmonary disease.
    Plant PJ; Brooks D; Faughnan M; Bayley T; Bain J; Singer L; Correa J; Pearce D; Binnie M; Batt J
    Am J Respir Cell Mol Biol; 2010 Apr; 42(4):461-71. PubMed ID: 19520920
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diaphragm weakness in pulmonary arterial hypertension: role of sarcomeric dysfunction.
    Manders E; de Man FS; Handoko ML; Westerhof N; van Hees HW; Stienen GJ; Vonk-Noordegraaf A; Ottenheijm CA
    Am J Physiol Lung Cell Mol Physiol; 2012 Dec; 303(12):L1070-8. PubMed ID: 22962018
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Diaphragm electrical activation in COPD patients].
    Bieleń P; Sliwiński P
    Pneumonol Alergol Pol; 2002; 70(7-8):378-86. PubMed ID: 12708079
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Application of skinned single muscle fibres to determine myofilament function in ageing and disease.
    Degens H; Larsson L
    J Musculoskelet Neuronal Interact; 2007; 7(1):56-61. PubMed ID: 17396007
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.